Greg Engel is CEO of Tilray, a Canadian company shaping the future of the global medical cannabis industry. Tilray is the only American-owned company to be a federally licensed producer of medical cannabis in Canada, where the company operates a $30 million, 60,000 sq. ft., state-of-the-art research, production and distribution center that delivers medical cannabis directly to thousands of patients every day. Greg has more than 25 years of progressive leadership experience in the pharmaceutical, biotechnology and medical device industries. Prior to joining Tilray, Engel led the commercial efforts of four successful health care companies, three in Canada and one globally. His former roles include: General Manager of Forest Laboratories Canada, General Manager of Encysive Canada, Chief Operating Officer of Northern Therapeutics and Director of Sales, Marketing and Regulatory Affairs for Atrax Medical Group.